The Hot Corner: Biotech, packaging, and regional banks

Thursday, April 30, 2026 Every day, we sift through the filings to spot where the real conviction lies – cutting through the noise to highlight the most meaningful insider moves.   📌 Zenas Biopharma $ZBIO — CEO purchased $1.07 Million via Form 4. A clear signal from the top—the CEO putting real money to work in the recent-issue biotech as it continues to find its footing post-IPO.   📌 Sonoco Products $SON — James A. Harrell III purchased $340,183 via Form 4. Another insider stepping in within the packaging name, adding to the ongoing trend of accumulation.   Here’s The Hot Corner, with data from April 29, 2026: Click the table to enlarge it. 📌 Huntington Bancshares $HBAN — James D. Rollins III purchased $111,085 via Form 4.   A smaller insider buy in the regional bank, with shares sitting near the upper end of a multi-year base.   📌 Janux Therapeutics $JANX — Point72 Asset Management increased its stake from 1.60% to 5.00% via 13G. The multi-strategy fund crosses the key 5% threshold, building a meaningful position in the choppy biotech name.   If you want this actionable trade ideas based on insider trading, join Hot Corner Insider risk-free. Alfonso De Pablos | Director of Research, All Star Charts Stock Market Media emails are a financial publication of general circulation and only offers impersonal advice, not tailored to individual needs of a specific client or group. Any comments or statements made herein do not necessarily reflect those of Stock Market Media LLC or its affiliates (collectively, "Stock Market Media") and do not constitute buy or sell recommendations. Unless specifically indicated, this message is not an official confirmation of any transaction. The contents of any email communications to or from Stock Market Media may be monitored or reviewed at Stock Market Media's discretion. Stock Market Media accepts no responsibility for any loss or damage arising in any way from the use of this transmission and any attachments; it is the responsibility of the recipient to ensure that they are virus free. If you reply to this email, please note that we are a public investor and do not want any material non-public information. We do not agree to keep confidential any information you provide and do not agree to any restrictions on our trading activity, except pursuant to a written confidentiality agreement executed by Stock Market Media. Want to change how you receive these emails? You can manage your preferences here unsubscribe. © 2026 Stock Market Media 624 Broadway, Suite 405 San Diego, CA 92101